Mixed Methods Study to Assess Family Members Unmet Needs in an Oncology Setting (SALUTE)

July 16, 2024 updated by: Swansea Bay University Health Board

The main questions the study aims to answer are:

  1. The proportion of family members of cancer patients who say they need more support
  2. What support family members feel would be beneficial

Information about patients' cancer diagnosis and treatment will be collected from their medical notes.

Participating family members will be asked to complete a telephone questionnaire. Selected family members may also be asked to participate in an optional follow-up interview.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

When someone is diagnosed with cancer, it can be a worrying and stressful time for patients and for their family members. Family members may provide practical and emotional support to patients, and may take on a caregiver role.

Family members may want more information or advice, or may benefit from emotional support themselves. The study aims to identify any gaps in the current support provided to family members so that services can be improved in the future.

Oncology patients in Singleton Hospital, Swansea will be asked by their oncology team to identify one or more family members to participate in the study. If a family member agrees to participate in the study, the research team will call them to complete a telephone questionnaire. The questionnaire should take less than 20 minutes and asks them some general questions (e.g. age, gender) and some questions about how they are feeling, what support services they find helpful and what additional support they feel would be beneficial.

Data regarding participating patients' cancer diagnosis and treatment will be collected from their medical notes.

After the questionnaire data has been analysed, optional follow-up interviews will be conducted with some family members to explore any issues identified in greater detail.

Patients and family members will be recruited during a 6 month recruitment period and all responses will be anonymised.

This is a pilot study which will not change the current support provided to family members, although they may be directed to existing services if appropriate. Patients' treatment will not be changed in any way.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Swansea, United Kingdom
        • South West Wales Cancer Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Oncology patients in South West Wales, United Kingdom

Description

Inclusion Criteria for patients

  • diagnosed with a solid organ malignancy under the care of the oncology team
  • able to identify at least one family member who may be willing to participate in the study

Inclusion Criteria for family members

- a family member of a patient diagnosed with a solid organ malignancy under the care of the oncology team

Exclusion Criteria for patients and family members

  • medical or psychiatric condition impairing ability to consent
  • the patient's treating oncologist's opinion is that participating in the study would cause severe distress to the patient or their family

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The proportion of family members who state they need more support
Time Frame: 6 months after start of study recruitment
The proportion of family members who state they need more support
6 months after start of study recruitment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Types of additional support that family members feel would be beneficial as identified via the telephone questionnaires and interviews
Time Frame: 6 months after start of study recruitment
This will be determined by qualitative analysis of questionnaire and interview data and may include improved psychological support, online resources, information leaflets etc
6 months after start of study recruitment
The proportion of family members who state they need more support with each of the Carer Support Needs Assessment Tool (CSNAT) domains
Time Frame: 6 months after start of study recruitment
he proportion of family members who state they need more support with each of the Carer Support Needs Assessment Tool (CSNAT) domains
6 months after start of study recruitment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sing Yu Moorcraft, Swansea Bay University Health Board

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2024

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

October 26, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 21, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2024

Last Update Submitted That Met QC Criteria

July 16, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 331660

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Telephone questionnaire

Subscribe